MX2016010447A - Composiciones y metodos para tratar diabetes y enfermedades hepáticas. - Google Patents

Composiciones y metodos para tratar diabetes y enfermedades hepáticas.

Info

Publication number
MX2016010447A
MX2016010447A MX2016010447A MX2016010447A MX2016010447A MX 2016010447 A MX2016010447 A MX 2016010447A MX 2016010447 A MX2016010447 A MX 2016010447A MX 2016010447 A MX2016010447 A MX 2016010447A MX 2016010447 A MX2016010447 A MX 2016010447A
Authority
MX
Mexico
Prior art keywords
compositions
methods
treating diabetes
liver diseases
diseases
Prior art date
Application number
MX2016010447A
Other languages
English (en)
Spanish (es)
Inventor
Prabhavathi Fernandes
Original Assignee
Cempra Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cempra Pharmaceuticals Inc filed Critical Cempra Pharmaceuticals Inc
Publication of MX2016010447A publication Critical patent/MX2016010447A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
MX2016010447A 2014-02-14 2015-02-11 Composiciones y metodos para tratar diabetes y enfermedades hepáticas. MX2016010447A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201461939961P 2014-02-14 2014-02-14
US201461984225P 2014-04-25 2014-04-25
US201462086911P 2014-12-03 2014-12-03
PCT/US2015/015353 WO2015123256A1 (en) 2014-02-14 2015-02-11 Compositions and methods for treating diabetes and liver diseases

Publications (1)

Publication Number Publication Date
MX2016010447A true MX2016010447A (es) 2016-12-20

Family

ID=53800574

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016010447A MX2016010447A (es) 2014-02-14 2015-02-11 Composiciones y metodos para tratar diabetes y enfermedades hepáticas.

Country Status (12)

Country Link
US (1) US20170165286A1 (OSRAM)
EP (1) EP3105234A4 (OSRAM)
JP (2) JP6553067B2 (OSRAM)
KR (1) KR20160113307A (OSRAM)
CN (1) CN106132969A (OSRAM)
AU (1) AU2015217293A1 (OSRAM)
CA (1) CA2939076A1 (OSRAM)
IL (1) IL247152A0 (OSRAM)
MX (1) MX2016010447A (OSRAM)
RU (1) RU2016133471A (OSRAM)
WO (1) WO2015123256A1 (OSRAM)
ZA (1) ZA201606199B (OSRAM)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008316830B2 (en) 2007-10-25 2016-03-17 Cempra Pharmaceuticals, Inc. Process for the preparation of macrolide antibacterial agents
US9072759B2 (en) 2008-10-24 2015-07-07 Cempra Pharmaceuticals, Inc. Biodefenses using triazole-containing macrolides
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
IN2014DN08939A (OSRAM) 2012-03-27 2015-05-22 Cempra Pharmaceuticals Inc
CA3111317C (en) 2012-09-17 2023-08-29 F. Hoffmann-La Roche Ltd. Method of synthesizing thyroid hormone analogs and polymorphs thereof
CN105163785A (zh) 2013-03-14 2015-12-16 森普拉制药公司 用于治疗呼吸道疾病的方法及其制剂
AU2017346871B2 (en) * 2016-10-18 2023-08-03 Madrigal Pharmaceuticals, Inc. Methods of treating liver disorders or lipid disorders with a THR-beta agonist
WO2018094265A2 (en) * 2016-11-21 2018-05-24 Viking Therapeutics, Inc. Method of treating glycogen storage disease
US12377104B1 (en) 2024-02-06 2025-08-05 Madrigal Pharmaceuticals, Inc. Methods for treating a fatty liver disease

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5760010A (en) * 1995-01-01 1998-06-02 Klein; Ira Method of treating liver disorders with a macrolide antibiotic
CA2411293A1 (en) * 1999-01-28 2000-07-28 Pfizer Products Inc. Novel azalides and methods of making same
FR2897154B1 (fr) * 2006-02-08 2008-03-07 Airbus France Sas Dispositif pour construire et securiser une trajectoire de vol a basse altitude destinee a etre suivie par un aeronef.
EP2077271A4 (en) * 2006-05-01 2010-09-15 Taisho Pharmaceutical Co Ltd Macrolide derivative
JP5025249B2 (ja) * 2006-12-15 2012-09-12 Ｎｓｋワーナー株式会社 発進クラッチ
JP5150740B2 (ja) * 2011-01-21 2013-02-27 株式会社小松製作所 作業車両
KR101618424B1 (ko) * 2011-08-30 2016-05-04 욱크하르트 리미티드 1,6-디아자비시클로[3,2,1]옥탄-7-온 유도체 및 세균 감염 치료에서의 그 유도체의 용도
US9078975B2 (en) * 2011-09-30 2015-07-14 Becton Dickinson France, S.A.S. Syringe having pivoting arm plunger rod

Also Published As

Publication number Publication date
RU2016133471A (ru) 2018-03-19
WO2015123256A1 (en) 2015-08-20
JP2019189639A (ja) 2019-10-31
US20170165286A1 (en) 2017-06-15
AU2015217293A1 (en) 2016-09-01
EP3105234A1 (en) 2016-12-21
ZA201606199B (en) 2020-01-29
IL247152A0 (en) 2016-09-29
RU2016133471A3 (OSRAM) 2018-09-24
EP3105234A4 (en) 2017-11-08
CN106132969A (zh) 2016-11-16
CA2939076A1 (en) 2015-08-20
JP6553067B2 (ja) 2019-07-31
JP2017505785A (ja) 2017-02-23
KR20160113307A (ko) 2016-09-28

Similar Documents

Publication Publication Date Title
MX2016010447A (es) Composiciones y metodos para tratar diabetes y enfermedades hepáticas.
LT3204015T (lt) Kompozicijos ir būdai, skirti hao1 (hidroksirūgšties oksidazė 1 (glikolato oksidazė)) genų raiškos slopinimui
EP3154557A4 (en) Acellular amnion derived therapeutic compositions
ZA201607573B (en) Novel compositions, uses and methods for making them
SG11201705450SA (en) Bacteria-comprising compositions and methods of using the same for treating and/or preventing gastrointestinal, metabolic and/or other diseases
EP3182979A4 (en) Novel compositions and methods useful for treating or preventing liver diseases or disorders, and promoting weight loss
EP3122872A4 (en) Compositions and methods for treating type 1 and type 2 diabetes and related disorders
EP3110446A4 (en) Methods and compositions for treating siglec-8 associated diseases
EP3132795A4 (en) Composition for preventing or treating fatty liver diseases
PT3552017T (pt) Compostos úteis como inibidores de ripk1
EP3142699A4 (en) Compositions and methods for treating metabolic disorders
IL248783A0 (en) Fluorescence quenching compounds, preparations containing them and their uses
EP3184113A4 (en) Pharmaceutical composition, comprising gold compound, for preventing or treating liver fibrosis or liver cirrhosis
EP3288636A4 (en) COMPOSITIONS FOR THE TREATMENT OF EPISTAXIS
SG11201606545SA (en) Pyrrole-substituted indolone derivative, preparation method therefor, composition comprising the same and use thereof
IL248256B (en) Cyclohexenyl compounds, compositions comprising them and uses thereof
EP3169405A4 (en) Methods, compounds, and compositions for the treatment of musculoskeletal diseases
EP3176149A4 (en) Method for improving preservation stability of 2,2-difluoroacetoaldehyde
GB201400267D0 (en) Algal bio-adhesives; compositions,process for manufacturing,formulations and uses
HK1255221A1 (zh) 使用卡多曲组合物进行治疗的方法
EP3135663A4 (en) Novel compound, and flavor composition containing said compound
PH12016501326A1 (en) (s)-3'-methyl-abscisic acid and esters thereof
EP3237399A4 (en) Compounds, compositions and methods
GB201513614D0 (en) Compositions, compounds and methods and uses relating thereto
ZA201608406B (en) Enzyme treatment composition